HAEMONETICS CORP — Director's Dealing 2023

May 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2023-05-12

Reporting Person: Miller Laurie A. (SVP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-12	Common Stock	F	32	$88.16	Disposed	12989	Direct

Footnotes

F1: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

F2: This number includes unvested RSUs previously reported, 198 shares acquired by the reporting person on October 31, 2022 under the Issuer's 2007 Employee Stock Purchase Plan (as amended, the "ESPP") and 126 shares acquired by the reporting person on April 28, 2023 under the ESPP.